Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Custodiol-HTK Solution as a Cardioplegic Agent- A Prospective Non-Inferiority Randomized Clinical Trial

NCT01681095 is registered in ClinicalTrials.gov with Marc Sakwa, MD as lead sponsor.

NCT NCT01681095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01681095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Custodiol-HTK Solution as a Cardioplegic Agent- A Prospective Non-Inferiority Randomized Clinical Trial
Lead sponsor
Marc Sakwa, MD
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
April 30, 2016
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary disease, heart diseases, myocardial ischemia, valvular heart disease